Predictors of mortality in patients undergoing autologous hematopoietic cell transplantation admitted to the intensive care unit

[1]  M. Skinner,et al.  Long-term outcome of patients with AL amyloidosis treated with high-dose melphalan and stem-cell transplantation. , 2007, Blood.

[2]  M. Björkholm,et al.  Predictors of short and long-term outcome in patients with hematological disorders admitted to the intensive care unit for a life-threatening complication , 2007, Supportive Care in Cancer.

[3]  L. Price,et al.  Blood stream infection after hematopoietic stem cell transplantation is associated with increased mortality , 2006, Bone Marrow Transplantation.

[4]  P. Hawkins,et al.  Outcome of autologous stem cell transplantation for AL amyloidosis in the UK , 2006, British journal of haematology.

[5]  Edward A Copelan,et al.  Hematopoietic stem-cell transplantation. , 2006, The New England journal of medicine.

[6]  D. White,et al.  Outcome of hematopoietic stem cell transplant recipients admitted to the intensive care unit. , 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[7]  R. Hills,et al.  Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient data meta-analysis of nine randomized trials. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  J. Bander,et al.  Outcome and prognostic factors of hematopoietic stem cell transplantation recipients admitted to a medical ICU. , 2004, Chest.

[9]  R. Falk,et al.  High-Dose Melphalan and Autologous Stem-Cell Transplantation in Patients with AL Amyloidosis: An 8-Year Study , 2004, Annals of Internal Medicine.

[10]  W. Dunn,et al.  Intensive care unit support and Acute Physiology and Chronic Health Evaluation III performance in hematopoietic stem cell transplant recipients. , 2003, Critical care medicine.

[11]  A. Dispenzieri,et al.  Stem cell transplantation for the management of primary systemic amyloidosis. , 2002, The American journal of medicine.

[12]  S. Dzik.  Early goal-directed therapy in the treatment of severe sepsis and septic shock , 2002 .

[13]  B. Horisberger,et al.  Economics, health care systems and utilization of haematopoietic stem cell transplants in Europe , 2002, British journal of haematology.

[14]  A. Bowcock,et al.  Multisystem dystrophy syndrome due to novel missense mutations in the amino-terminal head and alpha-helical rod domains of the lamin A/C gene. , 2002, The American journal of medicine.

[15]  E. Ivers,et al.  Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic Shock , 2001 .

[16]  R. Ramphal,et al.  Evolution, incidence, and susceptibility of bacterial bloodstream isolates from 519 bone marrow transplant patients. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  S. Chevret,et al.  Improved survival in cancer patients requiring mechanical ventilatory support: Impact of noninvasive mechanical ventilatory support , 2001, Critical care medicine.

[18]  D. Schoenfeld,et al.  Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. , 2000, The New England journal of medicine.

[19]  S. Nantel,et al.  Admission of bone marrow transplant recipients to the intensive care unit: outcome, survival and prognostic factors , 1998, Bone Marrow Transplantation.

[20]  G. Rubenfeld,et al.  Withdrawing Life Support from Mechanically Ventilated Recipients of Bone Marrow Transplants: A Case for Evidence-Based Guidelines , 1996, Annals of Internal Medicine.

[21]  J. Vincent,et al.  The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure , 1996, Intensive Care Medicine.

[22]  B. Afessa,et al.  Outcome of recipients of bone marrow transplants who require intensive-care unit support. , 1992, Mayo Clinic proceedings.

[23]  D. Schwartz,et al.  Mechanical ventilation after marrow transplantation. Risk factors and clinical outcome. , 1988, The American review of respiratory disease.

[24]  J. L. Gall,et al.  APACHE II--a severity of disease classification system. , 1986, Critical care medicine.

[25]  H. Lazarus,et al.  Transfer of the hematopoietic stem cell transplant patient to the intensive care unit: does it really matter? , 2006, Bone Marrow Transplantation.

[26]  E. Domínguez de Villota,et al.  Prognostic assessment of the acute complications of bone marrow transplantation requiring intensive therapy , 2004, Intensive Care Medicine.

[27]  B. Barlogie,et al.  Outcome from mechanical ventilation after autologous peripheral blood stem cell transplantation. , 2002, Chest.

[28]  P. Thall,et al.  Prognostic indicators for blood and marrow transplant patients admitted to an intensive care unit. , 1998, American journal of respiratory and critical care medicine.

[29]  J. Vose,et al.  Rapid immunologic reconstitution following transplantation with mobilized peripheral blood stem cells as compared to bone marrow , 1997, Bone Marrow Transplantation.